AI-generated summary
The authors studied low-level laser therapy at 660 nm or 780 nm on oral dysplastic and oral cancer cell lines grown in the laboratory. They report that the light modified cell growth through the Akt/mTOR/CyclinD1 pathway and increased expression of some proteins linked to progression and invasion. The study was conducted on cell lines, so its findings cannot be directly applied to patients.
- Who or what was studied
- Cultured oral dysplastic (DOK) and oral cancer (SCC9, SCC25) cell lines; no human participants.
- Wavelengths
- 660, 780 nm
- Limits stated in the abstract
- The study used cell lines only, not patients or animals, so clinical relevance is unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 780 nm
- Power
- 40 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Oral mucositis, Wound healing, Phototherapy, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.